Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04426539 · ClinicalTrials.gov registry record
New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study
A clinical trial, sponsored by American College of Radiology.
- Completed
- Registry status
- 6,061
- Enrollment target
NCT04426539: Completed study, sponsored by American College of Radiology.
NCT04426539 is a clinical trial that has completed, run by American College of Radiology. The registered enrollment target is 6,061 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04426539 has completed, sponsored by American College of Radiology.
- COMPLETED
- Registry status
- 6,061 participants
- Enrollment target
Study Summary
New IDEAS is an observational, open-label, longitudinal cohort study designed to address the requirements of the CED provisions of the NCD on beta-amyloid PET. Building on the initial Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study, New IDEAS will evaluate the association between amyloid PET and patient-centered outcomes in an expanded and more ethnoracially and clinically diverse group of Medicare participants presenting with cognitive impairment.
Primary Outcome
To compare 12-month claims-derived health outcomes in amyloid PET-positive versus amyloid PET-negative individuals presenting with MCI and dementia in the entire study cohort of diverse Medicare beneficiaries.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,061 participants |
| Start Date | 2020-12-17 |
| Est. Completion | 2024-12-31 |
What the finished NCT04426539 record still lists
NCT04426539 is an observational study that tracks outcomes without assigning an intervention. Its 6,061 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04426539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04426539 about?
NCT04426539 is a clinical study titled "New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study". New IDEAS is an observational, open-label, longitudinal cohort study designed to address the requirements of the CED provisions of the NCD on beta-amyloid PET. Building on the initial Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study, New IDEAS will evaluate the association between amyloi...
What is the current status of trial NCT04426539?
This trial is currently completed. The enrollment target is 6,061 participants. The study started on 2020-12-17. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT04426539?
This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI